Related Experiment Video
Updated: May 12, 2026

14:51
Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples
Published on: November 13, 2021
Serum proteomics in biomedical research: a systematic review
Ai-hua Zhang1, Hui Sun, Guang-li Yan
1National TCM Key Lab of Serum Pharmacochemistry, Key Lab of Chinmedomics, and Heilongjiang University of Chinese Medicine, Key Pharmacometabolomics Platform of Chinese Medicines, Heping Road 24, Harbin 150040, China.
Applied Biochemistry and Biotechnology
|April 24, 2013
Summary
Serum proteomics offers a powerful tool for early disease diagnosis by identifying key protein biomarkers. Advancements in proteomic technologies enable comprehensive analysis of serum proteins, revolutionizing disease detection and diagnostics.
Area of Science:
- Biochemistry
- Proteomics
- Biomarker Discovery
Background:
- Proteins in serum indicate physiological or pathological states, aiding early disease diagnosis and mechanism identification.
- Serum is an accessible, cost-effective medium for disease detection, with potential to revolutionize diagnostics.
- Differentially expressed serum proteins are crucial for monitoring disease status.
Purpose of the Study:
- To review the value of serum as a diagnostic tool.
- To summarize proteomic technologies for serum protein analysis.
- To elaborate on serum proteomics for disease biomarker discovery and diagnostics.
Main Methods:
- Review of emerging proteomic techniques for global serum protein analysis.
- Analysis of serum proteome for biomarker identification.
- Discussion of applications in clinical diagnostics.
Main Results:
- Serum proteomics is recognized as an excellent diagnostic medium.
- Comprehensive human serum proteome analysis offers potential for new biomarker discovery.
- Advancements facilitate disease diagnostics through serum analysis.
Conclusions:
- Serum proteomics is a credible diagnostic tool with high potential.
- Emerging technologies enable accurate and comprehensive serum analysis.
- This field presents critical challenges and future perspectives for disease biomarker discovery.
